Active

Lumira Ventures

General contacts

Investor type

Founded

2007

AUM

$699 M

Location

Toronto, Ontario, Canada

Investment Ticket

$10-50 m

Investment Stage

Series A Seed Pre-seed Late Stage (Series C+) Series B

Region of investment

North America Europe

Investor profile last updated: 16 September, 2026

Profile

Lumira Ventures is a life sciences venture capital firm based in Toronto, with additional offices in Montréal, Vancouver, and Boston. Founded in 2010, they focus on empowering mission-driven entrepreneurs to create and commercialize impactful products for patients. The team is composed of experienced professionals, including venture fellows, who collaborate closely with portfolio companies to drive innovation in the healthcare space. They have gained recognition for their strategic investments and have been awarded as VC Global Dealmaker of the Year by the Canadian Venture Capital and Private Equity Association.

Lumira Ventures targets investments in the life sciences sector, specifically in healthtech and medical devices, focusing on North America. They typically invest in Series B to late-stage rounds. As a venture capital firm, their investment size ranges from $10-50 million per deal, supporting companies as they advance through critical stages of development and commercialization.

Notable investments include Contraline, which focuses on male contraception, Sound Blade Medical for histotripsy therapy, and HistoSonics, known for new clinical applications. They have also participated in a $52.5 million Series B for Nervonik, which develops peripheral nerve stimulation therapy.

Industry

Software Pharmaceuticals IT Services Digital Biotechnology Healthcare Services Medical Devices Life Sciences HealthTech Robotics

Lumira Ventures Funds

Name	Type	Industry	Stage	Region	Size	AUM	Launch date
Lumira Ventures IV	Venture Capital (VC)	Healthcare Services Life Sciences HealthTech	Pre-seed Seed	North America Europe	$5-10 m	$220 M	July 2021
Lumira Ventures III	Venture Capital (VC)	Biotechnology Healthcare Services Medical Devices HealthTech	Pre-seed Seed	North America Europe	$5-10 m	$179 M	June 2017
Merck Lumira Biosciences Fund	Venture Capital (VC)	Biotechnology Life Sciences	Pre-seed Seed	Europe	$5-10 m	$43 M	March 2012
Lumira Ventures V	Venture Capital (VC)	Biotechnology Digital Healthcare Services Robotics Life Sciences HealthTech Medical Devices	Pre-seed Seed Series B Late Stage (Series C+)	North America Europe	$5-10 m	$200 M	April 2026

Contacts

Name

Title

Social Networks

Ben Constable Managing Director Australia

Managing Director Australia

b•••@•••

Michael Leung Controller

Controller

m•••@•••

Upgrade to see contacts

YOfVRyKip2dq30Tl YOfVRyKip2dq30Tl

YOfVRyKip2dq30Tl

[email protected]

YOfVRyKip2dq30Tl YOfVRyKip2dq30Tl

YOfVRyKip2dq30Tl

[email protected]

YOfVRyKip2dq30Tl YOfVRyKip2dq30Tl

YOfVRyKip2dq30Tl

[email protected]

Investment-team contacts for Lumira Ventures — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.

Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Lumira Ventures

Is Lumira Ventures a venture capital or private equity firm?

Lumira Ventures is a venture capital firm. It backs companies at Series A, Seed, Pre-seed, Late Stage (Series C+) and Series B, writing tickets of $10-50 m.

Where is Lumira Ventures located?

Lumira Ventures is located in Toronto, Ontario, Canada.

When was Lumira Ventures founded?

Lumira Ventures was founded in 2007.

What sectors and industries does Lumira Ventures invest in?

Lumira Ventures invests in companies and startups in Software, Pharmaceuticals, IT Services, Digital, Biotechnology, Healthcare Services, Medical Devices, Life Sciences, HealthTech, Robotics.

What is Lumira Ventures geographical focus of investments?

Lumira Ventures invests in companies and startups in North America, Europe.

At what stages of companies and startups does Lumira Ventures typically invest in?

Lumira Ventures invests in companies and startups at Series A, Seed, Pre-seed, Late Stage (Series C+), Series B.

What is the usual amount of Lumira Ventures investment?

Lumira Ventures usually invests $10-50 m on average.

What is the amount of assets of under management (AUM) for Lumira Ventures?

Lumira Ventures has around $699m assets under management.

When was Lumira Ventures last fund created?

Lumira Ventures last fund was created/launched in 2026-04-10

What are the contacts of Lumira Ventures?

Lumira Ventures can be reached through its website lumiraventures.com, its LinkedIn page and its X account. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Lumira Ventures — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

Can I access Lumira Ventures data via API or MCP?

Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Lumira Ventures directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.

When was the Lumira Ventures profile last updated?

Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 16 September, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.